<p>美国股指期货今晨走低，道琼斯期货周一下跌约 100 点。</p>
<p><strong>Ultragenyx Pharmaceutical Inc</strong>. RARE 的股票在盘前交易中大幅下跌。</p>
<p>Ultragenyx 收到了 FDA 针对 UX111 AAV 基因疗法治疗 A 型圣菲利波综合症（MPS IIIA）的完整回应函。</p>
<p>Ultragenyx Pharmaceutical 的股票在盘前交易中下跌 8%，至 27.15 美元。</p>
<h3>热门投资机会</h3>
<p>以下是一些在盘前交易中下跌的其他股票。</p>
<ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT 的股票在盘前交易中暴跌 31%，至 44.25 美元。MiNK Therapeutics 的股票在周五因公司宣布在《Oncogene》上发表文章而上涨 730%。</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE 的股票在盘前交易中下跌 21.3%，至 2.84 美元，此前在周五上涨 134%。Above Food Ingredients 最近宣布与 Palm Global 达成合并协议。</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG 的股票在盘前交易中下跌 11.3%，至 43.66 美元，此前在周五上涨 71%。</li>
<li><strong>CEL-SCI Corporation</strong> CVM 的股票在盘前交易中下跌 11%，至 3.08 美元，此前在周五下跌 8%。CEL-SCI 最近宣布与一家沙特阿拉伯制药和医疗公司签署了合作协议。</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC 的股票在盘前交易中下跌 8%，至 11.13 美元，此前在周五上涨 39%。</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS 的股票在盘前交易中下跌 6.6%，至 1.2700 美元。Gossamer Bio 上个月完成了其注册性 3 期 PROSERA 研究的入组，研究对象为肺动脉高压。</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT 的股票在盘前交易中下跌 4.1%，至 7.22 美元。Gilat Satellite Networks 最近宣布其商业部门从卫星运营商那里获得了超过 2200 万美元的订单。</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV 的股票在盘前交易中下跌 4%，至 13.94 美元，此前在周五下跌 6%。KalVista Pharma 最近公布的季度亏损超出预期。</li>
<li><strong>Apple Inc.</strong> AAPL 的股票在盘前交易中下跌 1%，至 209.22 美元。苹果公司正在进行重大管理重组。尽管公司面临多年来最大的危机，首席执行官蒂姆·库克仍然坚定掌舵。</li>
</ul>
<p><strong>现在阅读这个：</strong></p>
<ul>
<li><strong>本月可能会崩盘的前三只房地产股票</strong></li>
</ul>
<p>照片来源于 Shutterstock</p>

苹果

Ultragenyx制药

<p>美国股指期货今晨下跌，道琼斯期货下跌约 100 点。Ultragenyx 制药公司股价下跌 8%，至 27.15 美元，此前其基因疗法收到了 FDA 的完整回应函。其他显著下跌的股票包括 MiNK Therapeutics 下跌 31%，Above Food Ingredients 下跌 21.3%，Newegg Commerce 下跌 11.3%。苹果公司股价因管理层重组下跌 1%。总体来看，几只股票在近期上涨后出现显著的盘前亏损</p>

<p>U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday.</p>
<div class="lb-trans"><p>美国股指期货今晨走低，道琼斯期货周一下跌约 100 点。</p>
</div><p>Shares of <strong>Ultragenyx Pharmaceutical Inc</strong>. RARE fell sharply in pre-market trading.</p>
<div class="lb-trans"><p><strong>Ultragenyx Pharmaceutical Inc</strong>. RARE 的股票在盘前交易中大幅下跌。</p>
</div><p>Ultragenyx received a Complete Response Letter from the FDA for UX111 AAV gene therapy to treat Sanfilippo Syndrome Type A (MPS IIIA).</p>
<div class="lb-trans"><p>Ultragenyx 收到了 FDA 针对 UX111 AAV 基因疗法治疗 A 型圣菲利波综合症（MPS IIIA）的完整回应函。</p>
</div><p>Ultragenyx Pharmaceutical shares dipped 8% to $27.15 in the pre-market trading session.</p>
<div class="lb-trans"><p>Ultragenyx Pharmaceutical 的股票在盘前交易中下跌 8%，至 27.15 美元。</p>
</div><h3>Trending Investment Opportunities</h3>
<div class="lb-trans"><h3>热门投资机会</h3>
</div><p>Here are some other stocks moving lower in pre-market trading.</p>
<div class="lb-trans"><p>以下是一些在盘前交易中下跌的其他股票。</p>
</div><ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT shares tumbled 31% to $44.25 in pre-market trading. MiNK Therapeutics shares jumped 730% on Friday after the company announced a publication in Oncogene.</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE shares dipped 21.3% to $2.84 in pre-market trading after jumping 134% on Friday. Above Food Ingredients recently announced a merger agreement with Palm Global.</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG declined 11.3% to $43.66 in pre-market trading after gaining 71% on Friday.</li>
<li><strong>CEL-SCI Corporation</strong> CVM shares dipped 11% to $3.08 in pre-market trading after declining 8% on Friday. CEL-SCI recently announced it signed a partnership with a Saudi Arabian pharma and healthcare company.</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC slipped 8% to $11.13 in pre-market trading after gaining 39% on Friday.</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS declined 6.6% to $1.2700 in pre-market trading. Gossamer Bio, last month, completed enrollment in its registrational Phase 3 PROSERA study for pulmonary arterial hypertension</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT fell 4.1% to $7.22 in pre-market trading. Gilat Satellite Networks recently announced its commercial division received over $22 million in orders from satellite operators.</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV dipped 4% to $13.94 in pre-market trading after falling 6% on Friday. KalVista Pharma recently posted a wider-than-expected quarterly loss.</li>
<li><strong>Apple Inc.</strong> AAPL fell 1% to $209.22 in pre-market trading. Apple is in the midst of a significant management reshuffle. Despite the company's biggest crisis in years, CEO Tim Cook remains firmly at the helm.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT 的股票在盘前交易中暴跌 31%，至 44.25 美元。MiNK Therapeutics 的股票在周五因公司宣布在《Oncogene》上发表文章而上涨 730%。</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE 的股票在盘前交易中下跌 21.3%，至 2.84 美元，此前在周五上涨 134%。Above Food Ingredients 最近宣布与 Palm Global 达成合并协议。</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG 的股票在盘前交易中下跌 11.3%，至 43.66 美元，此前在周五上涨 71%。</li>
<li><strong>CEL-SCI Corporation</strong> CVM 的股票在盘前交易中下跌 11%，至 3.08 美元，此前在周五下跌 8%。CEL-SCI 最近宣布与一家沙特阿拉伯制药和医疗公司签署了合作协议。</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC 的股票在盘前交易中下跌 8%，至 11.13 美元，此前在周五上涨 39%。</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS 的股票在盘前交易中下跌 6.6%，至 1.2700 美元。Gossamer Bio 上个月完成了其注册性 3 期 PROSERA 研究的入组，研究对象为肺动脉高压。</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT 的股票在盘前交易中下跌 4.1%，至 7.22 美元。Gilat Satellite Networks 最近宣布其商业部门从卫星运营商那里获得了超过 2200 万美元的订单。</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV 的股票在盘前交易中下跌 4%，至 13.94 美元，此前在周五下跌 6%。KalVista Pharma 最近公布的季度亏损超出预期。</li>
<li><strong>Apple Inc.</strong> AAPL 的股票在盘前交易中下跌 1%，至 209.22 美元。苹果公司正在进行重大管理重组。尽管公司面临多年来最大的危机，首席执行官蒂姆·库克仍然坚定掌舵。</li>
</ul>
</div><p><strong>Now Read This:</strong></p>
<div class="lb-trans"><p><strong>现在阅读这个：</strong></p>
</div><ul>
<li><strong>Top 3 Real Estate Stocks That May Fall Off A Cliff This Month</strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong>本月可能会崩盘的前三只房地产股票</strong></li>
</ul>
</div><p>Photo via Shutterstock</p>
<div class="lb-trans"><p>照片来源于 Shutterstock</p>
</div>

Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session

- 美国股指期货今晨下跌，道琼斯期货下跌约 100 点。  
- Ultragenyx 制药公司因 FDA 发出完整回应信，股价在盘前交易中下跌 8%。  
- 其他股票如 MiNK Therapeutics 和 Above Food 也在盘前交易中大幅下跌。  

Ultragenyx 制药、苹果及其他大型股票在周一盘前交易中股价下跌